Списък на научните публикации на Доц. Д-р Росен Кирилов Николов, дм

1. 
   Спасова З., В. Дончев, Л. Боянова, С. Дередян, Р. Николов Някои промени в цитоскелета на епителните клетки на стомашната лигавицапри инфекция с Helicobakter pylori в резултата на Cag A. Българска хепатогастроентерология 2009; 2: 3-6
   
2. 
   Р Николов. Ендоскопско лигиране на варици на хранопровода – далечни резултати. J Clin Med 2009; 2, 10-13
   
3. 
   Николов Р. Ендоскопска папилосфинктеротомия при пациенти с изолирано повишение на ГГТ. Българска хепатогастроентерология 2008; 2: 7-10
   
4. 
   Боянова Л., Р. Николов, Л. Давидков, В. Камбуров, Г. Гергова, З. Спасова, Е. Лазарова, Хр. Желев, Н. Кацаров, И. Митов, З. Кръстев. Антибактерална резистентност и еволюция на резистентността на Helicobacter pylori при възрастни и деца. Инфектология 2007; XLIV (suppl. I): 44-46.
   
5. 
   Боянова, Л., Г. Гергова, Р. Николов, Л. Матева, З. Спасова, И. Митов, З. Кръстев. Анаеробна микробиология на клинични проби от жлъчен сок при пациенти с хронични инфекции на жлъчния тракт. Съвр. мед. 2007; LVIII (кн. 1): 17-23
   
6. 
   Боянова Л., Г. Железова, В. Камбуров, Р. Николов, Г. Гергова, Е. Лазарова, З. Спасова, Н. Кацаров, С. Дереджян, И. Митов, З. Кръстев. Проучване на Helicobacter pylori инфекцията чрез класически микробиологични методи и фекален антигенен тест. Българска хепатогастроентерология, 2, 2006, 14-19;
   
7. 
   Николов, Р., С. Дереджян, Л. Боянова. Балонна дилатация на доброкачествените стенози в гарния гастроинтестинален тракт. Българска хепатогастроентерология, 2, 2006, 3-13;
   
8. 
   Николов Р. Възможности на ендоскопската мукозна резекция. Българска хепатогастроентерология, 2, 2006, 35-41;
   
9. 
   Гегова А., В. Дончев, И. Михайлов, Б. Хубавешка, З. Спасова, С. Дереджян, Р. Николов, О. Косева, З. Кръстев. Морфологични промени в кръвоносните съдове на дебелочревна лигавица при болни с язвен колит. Съвременна медицина. 3, 2006, 16-21;
   
10. 
    Николов Р. Мукозна резекция и макробиопсия в диагностиката и ендоскопската терапия на някои болести на стомаха. Българска хепатогастроентерология, 2, 2005, 8-14;
    
11. 
    Боянова Л., Н. Кацаров, З. Спасова, Р. Николов, Е. Лазарова, Г. Гергова, С. Дереджян, Хр. Желев, И. Митов, З. Кръстев. Микробиологично проучване на общата, пост-терапевтична и вторична резистентност на Helicobacter pylori. Съвр. Мед. 2, 2005, 9-16;
    
12. 
    Боянова Л., З. Спасова, П. Янева, Г. Гергова, Н. Кацаров, С. Дереджян, Р. Куманова, Р. Николов, Е. Лазароза, И. Митов, З. Кръстев. Campilobacter инфекция при остър ентероколит и обостряне на хронични чревни заболявания. Съвременна медицина, год.LV, 2/2004, 18-24;
    
13. 
    Спасова З., В. Дончев, М. Милева, З. Кръстев, Л. Матева, Б. Хубавешка, Н. Костова, С. Дереджян, А. Алексиев, В. Цветкова, Т. Иванчев, Р. Николов, Н. Димитрова. Ендоскопска и морфологична характеристика на лигавицата на дебелото черво при болни с чернодробна цироза и портална. Българска хепатогастроентерология, 3, 2002, 51- 56;
    
14. 
    Владимиров Б., С. Николов, С. Дереджян, Р. Николов, Н. Кацаров, А. Михова, З. Кръстев, К. Чернев. Rabeprazole, Amoxicillin и ниски дози Claritromycin в лечението на дуоденална язва, съпроводена с H. pylori инфекция. Българска хепатогастроентерология, 3, 2002, 9-15.
    
15. 
    Кръстев З.,. Р. Николов, С. Дереджян, Л. Боянова. Азитромицин за ерадикация на H. pylori. Българска хепато-гастроентерология, 3, 2002, 16-21.
    
16. 
    Николов Р.. Причини за трудна канюлация на голямата дуоденална папила и подходи за преодоляването им. Българска хепатогастроентерология, 1, 2001, 22-25;
    
17. 
    Кръстев З. , З. Спасова, Р. Николов, Н. Кацаров, Е. Брадистилова. Лечение на дуоденалната язва в комбинация от Doxacyklin, Metronidazol и Ranitidin. Съвр.мед. XIV, 3, 1994; 24-26;
    
18. 
    Николов, Р., З. Спасова, С. Дереджян, З. Кръстев. Клиничен ефект от сукралфат-НИХВИ, при болни със стомашна и дуоденална язва. Съвр.мед. 41, 1990, 12, 26-28.
    

1. 
   Boyanova L, Nikolov R, Gergova G, Evstatiev I, Lazarova E, Kamburov V, Panteleeva E, Spassova Z, Mitov I. Two-decade trends in primary Helicobacter pylori resistance to antibiotics in Bulgaria. Diagn Microbiol Infect Dis. 2010 Aug;67(4):319-26.
   

2. 
   Boyanova L, Ilieva J, Gergova G, Spasova Z, Nikolov R, Davidkov L, Evstatiev I, Kamburov V, Katsarov N, Mitov I. Evaluation of clinical and sotio-demographic risk factors for antibacterial resistance of Helicobacter pylori in Bulgaria. Journal of Medical Microbiology 2009, 58, 94-100
   

3. 
   Boyanova L., Gergova G., Nikolov R., Davidkov L., Kamburov V., Jelev C., Mitov I. Prevalence and evolution of Helicobacter pylori resistance to antibacterial agents over 12 years and correlation between susceptibility testing methods. Diagn Microbiol Infect Dis . 2008; 60(4): 409-415
   

4. 
   Boyanova L, Nikolov R, Lazarova E, Gergova G, Katsarov N, Kamburov V, Spassova Z, Derejian S, Jelev C, Mitov I, Krastev Z.Antibacterial resistance in Helicobacter pylori strains isolated from Bulgarian children and adult patients over 9 years.J Med Microbiol. 2006 Jan;55(Pt 1):65-8.
   

5. 
   Boyanova L, Gergova G, Nikolov R, Derejian S, Lazarova E, Katsarov N, Mitov I, Krastev Z.Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods.J Med Microbiol. 2005 May;54(Pt 5):481-3.
   

6. 
   Boyanova L, Derejian S, Koumanova R, Katsarov N, Gergova G, Mitov I, Nikolov R, Krastev Z.Inhibition of Helicobacter pylori growth in vitro by Bulgarian propolis: preliminary report.J Med Microbiol. 2003 May;52(Pt 5):417-9.
   

7. 
   Boyanova L, Katsarov N, Gergova G, Nikolov R, Derejian S, Spassova Z, Mitov I, Krastev Z.Helicobacter pylori infection in elderly Bulgarian patients.J Med Microbiol. 2003 Dec;52(Pt 12):1131-3.
   

8. 
   Boyanova L, Koumanova R, Gergova G, Popova M, Mitov I, Kovacheva Y, Derejian S, Katsarov N, Nikolov R, Krastev Z. Prevalence of resistant Helicobacter pylori isolates in Bulgarian children.J Med Microbiol. 2002 Sep;51(9):786-90.
   

9. 
   Spassova,Z., L.Mateva,S.Martinov,R.Nicolov,N.Katzarov,Z.Krastev.Chlamydia trachomatis in Patients with Inflammatory Bowel Diseases,Nonspecific Colitis and Enteritis in Bulgaria.Recent Advances in Chemotherapy ( Proceedings of the 18th ICC ) American Society for Microbiology, Washington, 1994,62-63;
   

10. 
    Krastev Z, Mateva L, Danev S, Nikolov R.Clinical meaning of GGT activity in follow-up of patients with alcohol-related liver injury and cholestasis. Ital J Gastroenterol. 1992 May;24(4):185-7.
    

1. 
   Р. Николов.Ендоскопска класификация на вариците на хранопровода. В: КАК в гастроентерологията. Под ред. З. Кръстев. Прудента , София 1998; 31с.
   
2. 
   Р. Николов, З. Кръстев.Дисфункции на сфинктера на Oddi.В: КАК в гастроентерологията. Под ред. З. Кръстев. Прудента , София 1998; 192с.
   
3. 
   Р. Николов. Карцином на проксималния отдел на общия жлъчен проток. В: КАК в гастроентерологията. Под ред. З. Кръстев. Прудента , София 1998; 197с.
   
4. 
   Р. Николов. Ендоскопска ретроградна холангиопанкреатография. В: Тетрадка за студенти - ІІ. Под ред.З. Кръстев. Иван Сапунджиев ЕООД, Кюстендил 2001;293-295с;
   
5. 
   Р. Николов. Ендоскопска ретроградна холангиопанкреатография. В: Наръчник по хепатогастроентерология за фамилния лекар. Под ред.З. Кръстев. Иван Сапунджиев ЕООД, Кюстендил 2002;102с;
   

Increase in resistance rates of H.pylori isolates to metronidazole and tetracycline-comparison of three 3-year studies

(2010) Archives of Iranian Medicine, 13 (3), pp. 177-187.

http://www.scopus.com/inward/record.url?eid=2-s2.0-77953071160&partnerID=40&md5=d3ca54a8dea0fae46711381c1a901cf8

DOCUMENT TYPE: Article

SOURCE: Scopus

Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori

(2010) World Journal of Gastroenterology, 16 (10), pp. 1279-1284.

http://www.scopus.com/inward/record.url?eid=2-s2.0-77950150459&partnerID=40&md5=bc734b801c7a7254cddf6e7a201c847a

DOCUMENT TYPE: Article

SOURCE: Scopus

Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment

(2010) Digestive and Liver Disease, 42 (2), pp. 110-114.

http://www.scopus.com/inward/record.url?eid=2-s2.0-73749088673&partnerID=40&md5=7e0bcd0c4655594766106d72e7042d27

DOCUMENT TYPE: Article

SOURCE: Scopus

Effects of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori

(2010) World Chinese Journal of Digestology, 18 (3), pp. 262-267.

http://www.scopus.com/inward/record.url?eid=2-s2.0-77949308667&partnerID=40&md5=5fc9b5cd664965ddddc57f9f8f95c091

DOCUMENT TYPE: Article

SOURCE: Scopus

Bacterial resistance of Helicobacter pylori in the world in 2009 [Resistencia bacteriana del Helicobacter pylori en el mundo en el año 2009]

(2009) Acta Gastroenterologica Latinoamericana, 39 (4), pp. 282-290.

http://www.scopus.com/inward/record.url?eid=2-s2.0-73649092767&partnerID=40&md5=8020b68ee510a52c6355394bdbd4ef4d

DOCUMENT TYPE: Review

SOURCE: Scopus

Annual change of primary resistance to clarithromycin among helicobacter pylori isolates from 1996 through 2008 in Japan

(2009) Helicobacter, 14 (5), pp. 86-90. Cited 1 time.

http://www.scopus.com/inward/record.url?eid=2-s2.0-70349138895&partnerID=40&md5=c44354b5f1bce88edf64eaa23465d4fb

DOCUMENT TYPE: Article

SOURCE: Scopus

The role of active efflux in antibiotic - Resistance of clinical isolates of Helicobacter pylori

(2009) Indian Journal of Medical Microbiology, 27 (4), pp. 335-340. Cited 2 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-70349313141&partnerID=40&md5=ff5f6810921acd6817384a8b88e26e64

DOCUMENT TYPE: Article

SOURCE: Scopus

Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK

(2009) Journal of Medical Microbiology, 58 (10), pp. 1322-1328. Cited 1 time.

http://www.scopus.com/inward/record.url?eid=2-s2.0-70349338770&partnerID=40&md5=aad0514c2b35c8729f07e4f93fe72c7e

DOCUMENT TYPE: Article

SOURCE: Scopus

Antimicrobial susceptibility testing of Helicobacter pylori determined by microdilution method using a new medium

(2009) Current Microbiology, 58 (6), pp. 559-563.

http://www.scopus.com/inward/record.url?eid=2-s2.0-67349198113&partnerID=40&md5=85afab5053d78ae84b11dd9954063326

DOCUMENT TYPE: Article

SOURCE: Scopus

Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents

(2009) Chinese Journal of Contemporary Pediatrics, 11 (3), pp. 210-212.

http://www.scopus.com/inward/record.url?eid=2-s2.0-63049114497&partnerID=40&md5=a4593698d9b3a59b412bef532a057082

DOCUMENT TYPE: Article

SOURCE: Scopus

Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy

(2009) Archivum Immunologiae et Therapiae Experimentalis, 57 (1), pp. 45-56. Cited 2 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-63449112701&partnerID=40&md5=1e3d2e9614ba5f49538822d903a6279b

DOCUMENT TYPE: Review

SOURCE: Scopus

Acid related diseases progress in 2008 [Maladies peptiques]

(2009) Revue Medicale Suisse, 5 (187), pp. 167-175.

http://www.scopus.com/inward/record.url?eid=2-s2.0-59649124145&partnerID=40&md5=5effeb9a491c2395c66594aa31de3c01

DOCUMENT TYPE: Review

SOURCE: Scopus

Treatment of Helicobacter pylori infection

(2008) Helicobacter, 13 (SUPPL.1), pp. 35-40. Cited 11 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-49249136450&partnerID=40&md5=70533266ebd2d84c2d3e893bd8022fec

DOCUMENT TYPE: Article

SOURCE: Scopus

Helicobacter pylori infection in children

(2008) Helicobacter, 13 (SUPPL.1), pp. 41-46. Cited 4 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-49249083125&partnerID=40&md5=1a86185bf9e69e4b7e92f313cfac3bef

DOCUMENT TYPE: Article

SOURCE: Scopus

High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children

(2009) Revista Espanola de Quimioterapia, 22 (2), pp. 88-92. Cited 5 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-70349563749&partnerID=40&md5=247f7eff052e3700b54531520231c5d1

DOCUMENT TYPE: Article

SOURCE: Scopus

Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan

(2009) Journal of Gastroenterology and Hepatology, 24 (7), pp. 1230-1235. Cited 7 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-68749088899&partnerID=40&md5=a901aa9dcf3287c7d96ecf6bcc825e35

DOCUMENT TYPE: Article

SOURCE: Scopus

Prevalence of Helicobacter pylori primary resistance to antimicrobial agents in Poland and around the world [Wystȩpowanie pierwotnej oporności Helicobacter pylori na leki przeciwbakteryjne w polsce i na świecie]

(2009) Postepy Mikrobiologii, 48 (1), pp. 31-41.

http://www.scopus.com/inward/record.url?eid=2-s2.0-66649124292&partnerID=40&md5=4442e41c192b8139d352198edb8238c9

DOCUMENT TYPE: Review

SOURCE: Scopus

Helicobacter pylori and beyond: Pediatric peptic ulcer disease

(2009) Therapy, 6 (1), pp. 65-73. Cited 1 time.

http://www.scopus.com/inward/record.url?eid=2-s2.0-69849113782&partnerID=40&md5=cd24aacc6f848feacb279a7f1eaa78d8

DOCUMENT TYPE: Review

SOURCE: Scopus

Furazolidone, tetracycline and omeprazole: A low-cost alternative for Helicobacter pylori eradication in children

(2008) Jornal de Pediatria, 84 (2), pp. 160-165. Cited 1 time.

http://www.scopus.com/inward/record.url?eid=2-s2.0-43049118637&partnerID=40&md5=d04de0f20d722ecdd47edf60811ae6b4

DOCUMENT TYPE: Article

SOURCE: Scopus

Helicobacter pylori infection in children: Management and pharmacotherapy

(2008) Expert Opinion on Pharmacotherapy, 9 (4), pp. 577-585. Cited 2 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-40649096604&partnerID=40&md5=dc141d02941b899cf32a022e97ef412f

DOCUMENT TYPE: Review

SOURCE: Scopus

Helicobacter pylori primary resistant strains over 11 years in French children

(2007) Diagnostic Microbiology and Infectious Disease, 59 (2), pp. 217-222. Cited 10 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-34748851971&partnerID=40&md5=433fca8726037b5299cfd0202a7f3958

DOCUMENT TYPE: Article

SOURCE: Scopus

Eradication Therapy for Helicobacter pylori

(2007) Gastroenterology, 133 (3), pp. 985-1001. Cited 42 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-34548507671&partnerID=40&md5=675c478d7473ecf59a5173e11d377214

DOCUMENT TYPE: Review

SOURCE: Scopus

Peptic diseases [Maladies peptiques]

(2007) Revue Medicale Suisse, 3 (95), pp. 192-200.

http://www.scopus.com/inward/record.url?eid=2-s2.0-33846857966&partnerID=40&md5=f9d6f6deba842679194df5056435b018

DOCUMENT TYPE: Review

SOURCE: Scopus

Gastroduodenal diseases of childhood

(2006) Current Opinion in Gastroenterology, 22 (6), pp. 632-640. Cited 6 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-33750287625&partnerID=40&md5=ccb3a773aee688c452141abdfc3e94e0

DOCUMENT TYPE: Review

SOURCE: Scopus

From nobel to no cure: A case for monitoring antibiotic resistance in the gastric pathogen Helicobacter pylori

(2006) Expert Review of Anti-Infective Therapy, 4 (3), pp. 349-351.

http://www.scopus.com/inward/record.url?eid=2-s2.0-33745208232&partnerID=40&md5=04a043d90d49d28cc958779c8b7e6941

DOCUMENT TYPE: Editorial

SOURCE: Scopus

Mechanism of herpes simplex virus type 2 suppression by propolis extracts

(2010) Phytomedicine, 17 (2), pp. 132-138. Cited 1 time.

http://www.scopus.com/inward/record.url?eid=2-s2.0-73449120684&partnerID=40&md5=d4091c877d7bfcab1f07daf25e00b242

DOCUMENT TYPE: Article

SOURCE: Scopus

Antiviral activity and mode of action of propolis extracts and selected compounds

(2010) Phytotherapy Research, 24 (SUPPL. 1), pp. S20-S28. Cited 1 time.

http://www.scopus.com/inward/record.url?eid=2-s2.0-75749151225&partnerID=40&md5=aa5369445bceeb2df164af312b45b1bc

DOCUMENT TYPE: Article

SOURCE: Scopus

Antimicrobial activity of two propolis samples against human campylobacter jejuni

(2009) Journal of Medicinal Food, 12 (5), pp. 1050-1056.

http://www.scopus.com/inward/record.url?eid=2-s2.0-70350492509&partnerID=40&md5=80656a9b7f782e305849f6844b1ad137

DOCUMENT TYPE: Article

SOURCE: Scopus

Antagonism of Aeromonas hydrophila by propolis and its effect on the performance of Nile tilapia, Oreochromis niloticus

(2009) Fish and Shellfish Immunology, 27 (3), pp. 454-459.

http://www.scopus.com/inward/record.url?eid=2-s2.0-68949145934&partnerID=40&md5=e4058ee0de02e3f69098ae14b65aea69

DOCUMENT TYPE: Article

SOURCE: Scopus

Antagonism and action mechanism of antifungal metabolites from streptomyces rimosus MY02

(2009) Journal of Phytopathology, 157 (5), pp. 306-310.

http://www.scopus.com/inward/record.url?eid=2-s2.0-64049109687&partnerID=40&md5=dd80dd31a07afebeb61ff7d3108a136f

DOCUMENT TYPE: Article

SOURCE: Scopus

Practical Materia Medica: Propolis [Matière médicale pratique: Propolis]

(2009) Phytotherapie, 7 (2), pp. 100-105.

http://www.scopus.com/inward/record.url?eid=2-s2.0-65649097301&partnerID=40&md5=34c82c92543d56f4153b25e024223341

DOCUMENT TYPE: Article

SOURCE: Scopus

Bioactivities of polyphenolics from the roots of Bauhinia racemosa

(2008) Archives of Pharmacal Research, 31 (12), pp. 1525-1529.

http://www.scopus.com/inward/record.url?eid=2-s2.0-58449135798&partnerID=40&md5=0269ec6aadcc712883971251da221fc6

DOCUMENT TYPE: Article

SOURCE: Scopus

Comparative study of the antibacterial activity of propolis from different geographical and climatic zones

(2008) Phytotherapy Research, 22 (9), pp. 1256-1263. Cited 1 time.

http://www.scopus.com/inward/record.url?eid=2-s2.0-52649090230&partnerID=40&md5=822dae80d825f2b0909f8facd6407b27

DOCUMENT TYPE: Article

SOURCE: Scopus

Propolis reverses acetaminophen induced acute hepatorenal alterations: A biochemical and histopathological approach

(2008) Archives of Pharmacal Research, 31 (4), pp. 451-461. Cited 5 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-43049097150&partnerID=40&md5=5d1d7a58534eccb3e7dade2990b2b49f

DOCUMENT TYPE: Article

SOURCE: Scopus

Recent advances in the treatment of Helicobacter pylori infection

(2007) Recent Patents on Anti-Infective Drug Discovery, 2 (3), pp. 197-205. Cited 3 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-36749002870&partnerID=40&md5=76b33f2b5b6a684d32ab3412b8bb02ba

DOCUMENT TYPE: Article

SOURCE: Scopus

Brazilian green propolis on Helicobacter pylori infection. A pilot clinical study

(2007) Helicobacter, 12 (5), pp. 572-574. Cited 1 time.

http://www.scopus.com/inward/record.url?eid=2-s2.0-34548153045&partnerID=40&md5=754c72ffcd428629681a163f0093ebdc

DOCUMENT TYPE: Article

SOURCE: Scopus

Treatment of Helicobacter pylori

(2007) Best Practice and Research in Clinical Gastroenterology, 21 (2), pp. 315-324. Cited 19 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-33947276400&partnerID=40&md5=4ef855a536716a6092ca9c5fda060ca9

DOCUMENT TYPE: Article

SOURCE: Scopus

SFE of PMT mixture by supercritical CO2

(2006) CHISA 2006 - 17th International Congress of Chemical and Process Engineering, .

http://www.scopus.com/inward/record.url?eid=2-s2.0-34748836457&partnerID=40&md5=1498bd806c40d7e06aeeb07a93ed5484

DOCUMENT TYPE: Conference Paper

SOURCE: Scopus

'Rescue' therapies for the management of Helicobacter pylori infection

(2006) Digestive Diseases, 24 (1-2), pp. 113-130. Cited 21 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-33644537268&partnerID=40&md5=e59ac63b279c5cf251929295d6a93649

DOCUMENT TYPE: Review

SOURCE: Scopus

Intergenerational communication satisfaction and age boundaries in Bulgaria and the United States

(2010) Journal of Cross-Cultural Gerontology, 25 (2), pp. 133-147.

http://www.scopus.com/inward/record.url?eid=2-s2.0-77952425532&partnerID=40&md5=f7d4c6f1246d752ebedb722ea51269be

DOCUMENT TYPE: Article

SOURCE: Scopus

Antimicrobial activity of root extract and crude fractions of Croton zambesicus

(2010) Pakistan Journal of Pharmaceutical Sciences, 23 (1), pp. 114-118.

http://www.scopus.com/inward/record.url?eid=2-s2.0-75649139531&partnerID=40&md5=3d3777db6cb6b934e1e8054e213d4067

DOCUMENT TYPE: Article

SOURCE: Scopus

Antimicrobial activity of two propolis samples against human campylobacter jejuni

(2009) Journal of Medicinal Food, 12 (5), pp. 1050-1056.

http://www.scopus.com/inward/record.url?eid=2-s2.0-70350492509&partnerID=40&md5=80656a9b7f782e305849f6844b1ad137

DOCUMENT TYPE: Article

SOURCE: Scopus

Antimicrobial activity against Helicobacter pylori strains and antioxidant properties of blackberry leaves (Rubus ulmifolius) and isolated compounds

(2009) International Journal of Antimicrobial Agents, 34 (1), pp. 50-59. Cited 2 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-67349127128&partnerID=40&md5=d1edf2182c5ddcd695faad228398f854

DOCUMENT TYPE: Article

SOURCE: Scopus

High-throughput microbial bioassays to screen potential New Zealand functional food ingredients intended to manage the growth of probiotic and pathogenic gut bacteria

(2008) International Journal of Food Science and Technology, 43 (12), pp. 2257-2267. Cited 2 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-56349087986&partnerID=40&md5=ae2bb0bb053934e695fa49f55d7b4788

DOCUMENT TYPE: Article

SOURCE: Scopus

Efficacy and tolerance of a hypoallergenic propolis special extract GH 2002 in the galenic form of a shower gel/shampoo on patients with acne vulgaris - A open dermatologic study [Wirksamkeit und Verträglichkeit eines hypoallergenen Propolis Spezial Extraktes GH 2002 in der galenischen Form eines Duschgels /Shampoo bei Patienten mit Acne vulgaris - Eine offene dermatologische Studie]

(2008) Kosmetische Medizin, 29 (3), pp. 142-147. Cited 1 time.

http://www.scopus.com/inward/record.url?eid=2-s2.0-48649090576&partnerID=40&md5=f113108538af567123a092297714f2bf

DOCUMENT TYPE: Article

SOURCE: Scopus

Utilization of caffeic acid phenethyl ester to control Alternaria alternata rot in tomato (Lycopersicon esculentum Mill.) fruit

(2008) Journal of Phytopathology, 156 (3), pp. 164-173.

http://www.scopus.com/inward/record.url?eid=2-s2.0-38849209131&partnerID=40&md5=e8c1437ba3b04137ee59bd0e6d6e1870

DOCUMENT TYPE: Article

SOURCE: Scopus

Antidiarrhoeal and antimicrobial activities of Emilia coccinea (Sims) G. Don extracts

(2007) Journal of Ethnopharmacology, 112 (2), pp. 278-283. Cited 6 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-34248573827&partnerID=40&md5=39c42b617b9e00f4d10b08e17ca9c14a

DOCUMENT TYPE: Article

SOURCE: Scopus

The effect of bee propolis on recurrent aphthous stomatitis: A pilot study

(2007) Clinical Oral Investigations, 11 (2), pp. 143-147. Cited 8 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-34249714761&partnerID=40&md5=ef2757f7e6956b76294c96b45267e55a

DOCUMENT TYPE: Article

SOURCE: Scopus

Effect and local tolerability of a shampoo containing the propolis special extract GH 2002 in dermatitis seborrhoica with distinct dandruff formation [Wirkung und lokale verträglichkeit eines Shampoo mit dem Propolis Spezialextrakt GH 2002 bei Dermatitis seborrhoica mit ausgeprägter Kopfschuppenbildung]

(2007) Kosmetische Medizin, 28 (2), pp. 76-80. Cited 2 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-34249097059&partnerID=40&md5=02efe3c8dbda562671363b53c4048c4d

DOCUMENT TYPE: Article

SOURCE: Scopus

Evaluation of densitometric TLC for quantitative analysis of selected phenolic acids for standardization of propolis concentrates

(2006) Journal of Planar Chromatography - Modern TLC, 19 (112), pp. 449-453. Cited 2 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-33845951358&partnerID=40&md5=a98fcf231fa18df677d45a84ee68801d

DOCUMENT TYPE: Article

SOURCE: Scopus

Reversed-phase high-performance liquid chromatography determination of selected phenolic acids in propolis concentrates in terms of standardization for drug manufacturing purposes

(2006) Journal of AOAC International, 89 (2), pp. 352-358. Cited 4 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-33646823453&partnerID=40&md5=0da722e9996ca874a441af12304dc3e0

DOCUMENT TYPE: Article

SOURCE: Scopus

Showering gel and shampoo with a special concentrate from propolis for the treatment of seborrhoic eczema, psoriasis and atopic eczema - An observational study [Duschgel und shampoo mit einem propolis-spezial-konzentrat bei seborrhoe, psoriasis, und atopischen ekzemen - Eine anwendungsbeobachtung]

(2005) Haut, 16 (7), pp. 311-315.

http://www.scopus.com/inward/record.url?eid=2-s2.0-30444446817&partnerID=40&md5=5e43e540637b26cd59f6658cc359bd14

DOCUMENT TYPE: Article

SOURCE: Scopus

Non-antibiotic therapies for Helicobacter pylori infection

(2005) European Journal of Gastroenterology and Hepatology, 17 (9), pp. 973-981. Cited 12 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-23944512186&partnerID=40&md5=2b7a6c86b7f8483c19ec34d7b592f639

DOCUMENT TYPE: Review

SOURCE: Scopus

A novel colorimetric broth microdilution method to determine the minimum inhibitory concentration (MIC) of antibiotics and essential oils against Helicobacter pylori

(2005) Pharmazie, 60 (7), pp. 498-502. Cited 3 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-22644445911&partnerID=40&md5=638df6985bd6a3ad38ce1aea9b9a5ea0

DOCUMENT TYPE: Article

SOURCE: Scopus

Antibacterial effect of plant extracts against Helicobacter pylori

(2005) Phytotherapy Research, 19 (3), pp. 198-202. Cited 24 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-20444436332&partnerID=40&md5=026f6b9b5e98f00331f3310c555e7810

DOCUMENT TYPE: Article

SOURCE: Scopus

Therapy of Helicobacter pylori

(2004) Helicobacter, 9 (SUPPL. 1), pp. 42-48. Cited 32 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-4644280540&partnerID=40&md5=f115b1e1297f3f9792e533adc256e13b

DOCUMENT TYPE: Review

SOURCE: Scopus

Sprouting and solid-state bioprocessing by Rhizopus oligosporus increase the In Vitro antibacterial activity of aqueous soybean extracts against Helicobacter pylori

(2004) Food Biotechnology, 18 (2), pp. 229-249. Cited 4 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-4043071349&partnerID=40&md5=452220f01a46dd17dbe504f97d889da8

DOCUMENT TYPE: Article

SOURCE: Scopus

A randomized controlled trial: Efficacy and safety of azithromycin, ofloxacin, bismuth, and omeprazole compared with amoxicillin, clarithromycin, bismuth, and omeprazole as second-line therapy in patients with helicobacter pylori infection

(2010) Helicobacter, 15 (2), pp. 154-159.

http://www.scopus.com/inward/record.url?eid=2-s2.0-77749233911&partnerID=40&md5=53e0e4ebd4962d1c9fca080c8d71a65c

DOCUMENT TYPE: Article

SOURCE: Scopus

The resistance to antibiotics in Helicobacter pylori [La resistencia a antibióticos en Helicobacter pylori]

(2008) Revista Cubana de Medicina, 47 (4), .

http://www.scopus.com/inward/record.url?eid=2-s2.0-66049110237&partnerID=40&md5=233542cee2327a4dcc82e13b76075e3a

DOCUMENT TYPE: Article

SOURCE: Scopus

Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005

(2007) Journal of Clinical Microbiology, 45 (12), pp. 4006-4010. Cited 16 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-37249090223&partnerID=40&md5=4e00b0c15c1086c97b3ce14ce051b225

DOCUMENT TYPE: Article

SOURCE: Scopus

Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens

(2006) National Medical Journal of China, 86 (38), pp. 2679-2682.

http://www.scopus.com/inward/record.url?eid=2-s2.0-33845906075&partnerID=40&md5=c418ff3164793cc5aedfd1d2f250a0cb

DOCUMENT TYPE: Article

SOURCE: Scopus

From nobel to no cure: A case for monitoring antibiotic resistance in the gastric pathogen Helicobacter pylori

(2006) Expert Review of Anti-Infective Therapy, 4 (3), pp. 349-351.

http://www.scopus.com/inward/record.url?eid=2-s2.0-33745208232&partnerID=40&md5=04a043d90d49d28cc958779c8b7e6941

DOCUMENT TYPE: Editorial

SOURCE: Scopus

One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication

(2005) Digestive and Liver Disease, 37 (8), pp. 571-576. Cited 15 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-28944441708&partnerID=40&md5=a7f55695d7d0bd5e141827ed9504b78d

DOCUMENT TYPE: Article

SOURCE: Scopus

Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea

(2004) Antimicrobial Agents and Chemotherapy, 48 (12), pp. 4843-4847. Cited 33 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-9644268940&partnerID=40&md5=c14131fe3e92588cf3ff8c2bae8eef00

DOCUMENT TYPE: Article

SOURCE: Scopus

H pylori antibiotic resistance: Prevalence, importance, and advances in testing

(2004) Gut, 53 (9), pp. 1374-1384. Cited 176 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-4344592305&partnerID=40&md5=5bfac4b14ed4e8a1327fe91a0b84458a

DOCUMENT TYPE: Review

SOURCE: Scopus

Resistance to antibiotics used in Helicobacter pylori infection in children [Oporność na antybiotyki stosowane w zakażeniu Helicobacter pylori u dzieci]

(2004) Polski Merkuriusz Lekarski, 16 (96), pp. 543-546. Cited 2 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-3242798856&partnerID=40&md5=19fc59c3569ac8b0a0a9f402263d8a67

DOCUMENT TYPE: Article

SOURCE: Scopus

Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study

(2003) Journal of Gastroenterology and Hepatology, 18 (12), pp. 1373-1378. Cited 28 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-9144251738&partnerID=40&md5=f803dfd23c827e55c7cf85d5b300cdd0

DOCUMENT TYPE: Article

SOURCE: Scopus

Inhibition of Helicobacter pylori-induced Nuclear Factor-kappa B Activation and Interleukin-8 Gene Expression by Ecabet Sodium in Gastric Epithelial Cells

(2003) Helicobacter, 8 (5), pp. 542-553. Cited 15 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-0142122394&partnerID=40&md5=bf246ac9e3589ebd882cc4739baa9834

DOCUMENT TYPE: Article

SOURCE: Scopus

Prevalence of Helicobacter pylori resistance to clarithromycin and metronidazole determined by 23S ribosomal RNA and rdxA gene analyses in Hiroshima, Japan

(2003) Journal of Gastroenterology and Hepatology, 18 (10), pp. 1202-1207. Cited 9 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-10744231830&partnerID=40&md5=1965fa21c2d331668fc3e27f21cad74a

DOCUMENT TYPE: Article

SOURCE: Scopus

Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates

(2003) BMC Gastroenterology, 3, art. no. 20, . Cited 31 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-2442713982&partnerID=40&md5=98ff72c6376eb75ebb51b9b04abf1bb3

DOCUMENT TYPE: Article

SOURCE: Scopus

The effects of dietary flaxseed on the Fischer 344 rat. III. Protection against CCl4-induced liver injury

(2005) Cell Biochemistry and Function, 23 (6), pp. 389-398.

http://www.scopus.com/inward/record.url?eid=2-s2.0-27844599612&partnerID=40&md5=2b48b7076d9744ea753a18763df19c61

DOCUMENT TYPE: Article

SOURCE: Scopus

Biochemical diagnosis of alcoholism

(2005) Indian Journal of Clinical Biochemistry, 20 (1), pp. 35-42. Cited 8 times.

http://www.scopus.com/inward/record.url?eid=2-s2.0-14944384926&partnerID=40&md5=1bb8403ecc17792c24778674d83e76a9

DOCUMENT TYPE: Article

SOURCE: Scopus